Literature DB >> 19889281

Pregabalin as treatment for fibromyalgia: the rest of the story?

Andrew J Holman1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19889281     DOI: 10.1007/s11916-009-0079-9

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


× No keyword cloud information.
  9 in total

1.  The incidence of fibromyalgia and its associated comorbidities: a population-based retrospective cohort study based on International Classification of Diseases, 9th Revision codes.

Authors:  Peter T Weir; Gregory A Harlan; Flo L Nkoy; Spencer S Jones; Kurt T Hegmann; Lisa H Gren; Joseph L Lyon
Journal:  J Clin Rheumatol       Date:  2006-06       Impact factor: 3.517

Review 2.  Is fibromyalgia a distinct clinical entity? The clinical investigator's evidence.

Authors:  I J Russell
Journal:  Baillieres Best Pract Res Clin Rheumatol       Date:  1999-09       Impact factor: 4.098

3.  A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications.

Authors:  Andrew J Holman; Robin R Myers
Journal:  Arthritis Rheum       Date:  2005-08

4.  Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial.

Authors:  P J Siddall; M J Cousins; A Otte; T Griesing; R Chambers; T K Murphy
Journal:  Neurology       Date:  2006-11-28       Impact factor: 9.910

5.  Neurologic signs and symptoms in fibromyalgia.

Authors:  Nathaniel F Watson; Dedra Buchwald; Jack Goldberg; Carolyn Noonan; Richard G Ellenbogen
Journal:  Arthritis Rheum       Date:  2009-09

6.  Positional cervical spinal cord compression and fibromyalgia: a novel comorbidity with important diagnostic and treatment implications.

Authors:  Andrew J Holman
Journal:  J Pain       Date:  2008-05-22       Impact factor: 5.820

7.  The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee.

Authors:  F Wolfe; H A Smythe; M B Yunus; R M Bennett; C Bombardier; D L Goldenberg; P Tugwell; S M Campbell; M Abeles; P Clark
Journal:  Arthritis Rheum       Date:  1990-02

8.  Treatment of cervical myelopathy in patients with the fibromyalgia syndrome: outcomes and implications.

Authors:  Dan S Heffez; Ruth E Ross; Yvonne Shade-Zeldow; Konstantinos Kostas; Mary Morrissey; Dean A Elias; Alan Shepard
Journal:  Eur Spine J       Date:  2007-04-11       Impact factor: 3.134

9.  Characteristics and healthcare costs of patients with fibromyalgia syndrome.

Authors:  A Berger; E Dukes; S Martin; J Edelsberg; G Oster
Journal:  Int J Clin Pract       Date:  2007-07-26       Impact factor: 2.503

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.